TORONTO – Apotex Health Corp. says it has filed a preliminary prospectus for an initial public offering that will see the Canadian generic drug company join the public market.
The Toronto-based company says the plan includes a treasury offering of shares and a secondary offering by certain shareholders, including SK Capital Partners, the company’s controlling shareholder.
